Biotech
View All
Opinion: The lesson biotech absolutely should not take from Silicon Valley Bank’s failure
As a five-time biotech CEO, I’ve guided my companies through recessions, supply chain disruptions, Wall Street volatility, even a global pandemic. Yet nothing quite prepared me for the news on …
Health Tech
View All
Opinion: AI chatbots can improve health — but only with help from humans
Chatbots like OpenAI’s ChatGPT can hold fun conversations across many topics. But when it comes to providing people with accurate health information, they need help from humans. As tech enthusiasts …
Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered left shoulder and an allergy to pain medicine. In 16.6 days, …
‘Truth is losing the battle’: FDA commissioner on grappling with a wave of health misinformation
The Food and Drug Administration is considering whether it needs to revamp guidance on how FDA-regulated manufacturers should deal with online misinformation about their products as the agency continues to …
First Opinion
View AllOpinion: The lesson biotech absolutely should not take from Silicon Valley Bank’s failure
As a five-time biotech CEO, I’ve guided my companies through recessions, supply chain disruptions, Wall Street volatility, even a global pandemic. Yet nothing quite prepared me for the news on …
Opinion: The much-maligned ‘quality-adjusted life year’ is a vital tool for health care policy
Health policy circles have erupted in debate over a wonky administrative tool: the quality-adjusted life year (QALY) and similar metrics to value and price drugs and other health interventions. Rep. …
Opinion: Living kidney donors rely on a promise to protect our future health. We’re scared it will go away
Five years ago, I donated my “spare” kidney at the Mayo Clinic to a woman I read about in the newspaper. Though living with only one kidney has risks, I …
